NEOGENOMICS INC's ticker is and the CUSIP is 64049MAA8. A total of 23 filers reported holding NEOGENOMICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,161,719 | -49.9% | 1,250,000 | -50.0% | 0.00% | – |
| Q1 2023 | $2,320,312 | +121.5% | 2,500,000 | +100.0% | 0.00% | – |
| Q4 2022 | $1,047,656 | -3.0% | 1,250,000 | 0.0% | 0.00% | – |
| Q3 2022 | $1,080,000 | +4.0% | 1,250,000 | 0.0% | 0.00% | – |
| Q2 2022 | $1,038,000 | -2.6% | 1,250,000 | 0.0% | 0.00% | – |
| Q1 2022 | $1,066,000 | -28.0% | 1,250,000 | 0.0% | 0.00% | – |
| Q4 2021 | $1,481,000 | -19.7% | 1,250,000 | 0.0% | 0.00% | – |
| Q3 2021 | $1,845,000 | +4.1% | 1,250,000 | 0.0% | 0.00% | – |
| Q2 2021 | $1,772,000 | -5.7% | 1,250,000 | 0.0% | 0.00% | – |
| Q1 2021 | $1,880,000 | -53.9% | 1,250,000 | -50.0% | 0.00% | – |
| Q4 2020 | $4,078,000 | +30.5% | 2,500,000 | 0.0% | 0.00% | – |
| Q3 2020 | $3,125,000 | +16.8% | 2,500,000 | 0.0% | 0.00% | – |
| Q2 2020 | $2,675,000 | – | 2,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 42,653,000 | $41,567,428 | 0.65% |
| LINDEN ADVISORS LP | 49,111,000 | $47,690,263 | 0.40% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 40,019,000 | $39,043,537 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,500,000 | $6,305,559 | 0.10% |
| LAZARD ASSET MANAGEMENT LLC | 29,758,000 | $29,032 | 0.04% |
| JPMORGAN CHASE & CO | 395,000 | $383,348 | 0.00% |
| DEUTSCHE BANK AG\ | 36,000 | $34,762 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Amundi | 255,000 | $246,075 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,267,000 | $1,223,453 | 0.00% |